fulvestrant



fulvestrant


SMILES C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
InChIKey VWUXBMIQPBEWFH-WCCTWKNTSA-N

Chemical Properties

Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 14
Molecular weight (Da) 606.3


No bioactivity data available.

fulvestrant


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I
Phase II
Phase III
Phase IV


Compound is not listed as a drug.